1
|
Krzepiłko A, Matyszczuk KM, Święciło A. Effect of Sublethal Concentrations of Zinc Oxide Nanoparticles on Bacillus cereus. Pathogens 2023; 12:pathogens12030485. [PMID: 36986407 PMCID: PMC10053889 DOI: 10.3390/pathogens12030485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 03/10/2023] [Accepted: 03/17/2023] [Indexed: 03/30/2023] Open
Abstract
Zinc oxide nanoparticles (ZnONPs), which are produced on a large scale, pose a potential threat to various environments because they can interact with the microbial populations found in them. Bacteria that are widespread in soil, water, and plant material include the Bacillus cereus group, which plays an important role in biodegradation and the nutrient cycle and is a major factor determining ecological balance. This group includes, among others, the foodborne pathogen B. cereus sensu stricto (herein referred to as B. cereus). The aim of this study was a comprehensive assessment of the effects of commercially available ZnONPs on B. cereus. The MIC (minimum inhibitory concentration) for B. cereus was 1.6 mg/mL, and the MBC (minimum bactericidal concentration) was 1.8 mg/mL. Growth of B. cereus was inhibited by a concentration of ZnONPs lower than or equal to MIC50. Concentrations from 0.2 to 0.8 mg/mL inhibited the growth of these bacteria in liquid media, induced symptoms of oxidative stress, and stimulated an environmental stress response in the form of biofilm and endospore formation. In addition, ZnONPs negatively affected the ability of the bacteria to break down the azo dye Evans Blue but enhanced the antimicrobial properties of phenolic compounds. Sublethal concentrations of ZnONPs generally decreased the activity of B. cereus cells, especially in the presence of phenolics, which indicates their potential toxicological impact, but at the same time they induced universal defence responses in these cells, which in the case of potential pathogens can hinder their removal.
Collapse
Affiliation(s)
- Anna Krzepiłko
- Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 20-950 Lublin, Poland
| | - Katarzyna Magdalena Matyszczuk
- Department of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, 20-950 Lublin, Poland
| | - Agata Święciło
- Department of Environmental Microbiology, Faculty of Agrobioengineering, University of Life Sciences in Lublin, 20-069 Lublin, Poland
| |
Collapse
|
2
|
Yossa N, Huang S, Canida T, Binet R, Macarisin D, Bell R, Tallent S, Brown E, Hammack T. qPCR detection of viable Bacillus cereus group cells in cosmetic products. Sci Rep 2023; 13:4477. [PMID: 36934171 PMCID: PMC10024758 DOI: 10.1038/s41598-023-31128-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Accepted: 03/07/2023] [Indexed: 03/20/2023] Open
Abstract
Reference methods for microbiological safety assessments of cosmetics rely on culture methods that reveal colonies of live microorganisms on growth media. Rapid molecular technologies, such as qPCR, detects the presence of target DNA in samples from dead and viable cells. DNA intercalating dyes, such as propidium monoazide (PMAxx), are capable of restricting PCR amplification to viable microbial cells. Here we developed singleplex and multiplex real time (qPCR) assays for the detection of Bacillus cereus (B. cereus) using 16S rRNA and phosphatidylcholine-specific phospholipase C (PLC) gene specific sequences coupled with PMAxx. The limit of detection was determined to be ~ 1 log CFU/ml for 16S rRNA and 3 log CFU/ml for PLC detection in pure culture using an eye shadow isolate, B. cereus 3A. We assessed the inclusivity and exclusivity of our qPCR assays using 212 strains, including 143 members of B. cereus, 38 non- B. cereus. and 31 non-Bacillus species; inclusivity was 100% for the 16S rRNA and 97.9% for the PLC targets; the exclusivity was 100% for 16S rRNA and 98.6% for PLC targets. These qPCR assays were then used to assess samples of commercial cosmetics: one set of liquid face toners (N = 3), artificially contaminated with B. cereus 3A, and one set of powdered cosmetics (N = 8), previously determined to be contaminated with B. cereus. For some samples, test portions were analyzed by qPCR in parallel, with and without PMAxx treatment. All test portions were simultaneously streaked on BACARA plates to confirm viable cells of B. cereus, according to the culture method. We found no difference in sensitivity between the singleplex and the multiplex qPCR assays (P > 0.05). Inoculated samples that did not recover B. cereus on plates still showed amplification of the DNA targets. However, that amplification was significantly delayed in PMAxx -treated samples (P < 0.0001) with CT value differences of 7.82 for 16S rRNA and 7.22 for PLC. Likewise, amplification delay was significant (P < 0.0001) with inoculated samples that recovered B. cereus on plates with CT value differences of 2.96 and 2.36 for 16S rRNA and PLC, respectively, demonstrating the presence of dead cells in the samples. All our qPCR results correlated with detection on BACARA plates (kappa, k = 0.99), independently of the presence of PMAxx in the PCR assays. Nevertheless, the amplification threshold with PMAxx dyes was significantly higher than the non-PMAxx dyes. Our findings confirm qPCR can be used for more rapid detection of microorganisms in cosmetics, including B. cereus, and selective detection of viable cells can be improved using PMAxx dyes.
Collapse
Affiliation(s)
- Nadine Yossa
- FDA, Office of Regulatory Science, College Park, MD, USA.
| | - Sonny Huang
- Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37831, USA
| | - Travis Canida
- FDA, Office of Analytics and Outreach, College Park, MD, 20740, USA
| | - Rachel Binet
- FDA, Office of Regulatory Science, College Park, MD, USA
| | | | - Rebecca Bell
- FDA, Office of Regulatory Science, College Park, MD, USA
| | - Sandra Tallent
- FDA, Office of Regulatory Science, College Park, MD, USA
| | - Eric Brown
- FDA, Office of Regulatory Science, College Park, MD, USA
| | - Thomas Hammack
- FDA, Office of Regulatory Science, College Park, MD, USA.
| |
Collapse
|
3
|
Yossa N, Bell R, Tallent S, Brown E, Binet R, Hammack T. Genomic characterization of Bacillus cereus sensu stricto 3A ES isolated from eye shadow cosmetic products. BMC Microbiol 2022; 22:240. [PMID: 36199032 PMCID: PMC9533521 DOI: 10.1186/s12866-022-02652-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 09/20/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The Bacillus cereus group, also known as B. cereus sensu lato (s.l.) contains ubiquitous spore-forming bacteria found in the environment including strains from the B. cereus sensu stricto (s.s.) species. They occur naturally in a wide range of raw materials and in consumer products. Characterizing isolates that have survived in consumer products allows us to better understand the mechanisms that permit spores to persist and potentially cause illness. Here we characterize the draft genome sequence of B. cereus s. s. 3A-ES, originally isolated from eye shadow and since investigated in several cosmetic studies and compared it to other top ten published complete genome sequences of B. cereus s.l. members. RESULTS The draft genome sequence of B. cereus s.s. 3A ES consisted of an average of 90 contigs comprising approximately 5,335,727 bp and a GC content of 34,988%, and with 5509 predicted coding sequences. Based on the annotation statistics and comparison to other genomes within the same species archived in the Pathosystems Resource Integration Center (PATRIC), this genome "was of good quality. Annotation of B. cereus s.s. 3A ES revealed a variety of subsystem features, virulence factors and antibiotic resistant genes. The phylogenetic analysis of ten B. cereus group members showed B. cereus s.s. 3A-ES to be a closely related homolog of B. cereus s.s. ATCC 14,579, an established reference strain that is not adapted for cosmetic microbiological studies. Survival of 3A-ES in eye shadow could be linked to predicted stress-response genes and strengthened by additional stress-response genes such as VanB-type, VanRB, CAT15/16, BcrA, BcrB, Lsa(B), and recA that are lacking in B. cereus s.s. ATCC 14,579. CONCLUSION Our genomic analysis of B. cereus s.s. 3A-ES revealed genes, which may allow this bacterium to withstand the action of preservatives and inhibitors in cosmetics, as well as virulence factors that could contribute to its pathogenicity. Having a well-characterized strain obtained from eye-shadow may be useful for establishing a reference strain for cosmetics testing.
Collapse
Affiliation(s)
- Nadine Yossa
- Office of Regulatory Science, FDA, College Park, MD, 20740, USA.
| | - Rebecca Bell
- Office of Regulatory Science, FDA, College Park, MD, 20740, USA
| | - Sandra Tallent
- Office of Regulatory Science, FDA, College Park, MD, 20740, USA
| | - Eric Brown
- Office of Regulatory Science, FDA, College Park, MD, 20740, USA
| | - Rachel Binet
- Office of Regulatory Science, FDA, College Park, MD, 20740, USA
| | - Thomas Hammack
- Office of Regulatory Science, FDA, College Park, MD, 20740, USA
| |
Collapse
|
4
|
Zhang J, DI B, Shan H, Liu J, Zhou Y, Chen H, Hu L, Wu X, Bai Z. Rapid Detection of Bacillus cereus Using Cross-Priming Amplification. J Food Prot 2019; 82:1744-1750. [PMID: 31536421 DOI: 10.4315/0362-028x.jfp-19-156] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Bacillus cereus is a spore-forming gastrointestinal pathogen that can cause life-threatening diseases. Here, a simple and effective assay to detect B. cereus was developed, using cross-priming amplification (CPA). Amplicons were detected using disposable cartridges that contained nucleic acid detection strips. The sensitivity of CPA assay for B. cereus was assessed using serial dilutions of genomic DNA, which indicated a detection limit of 3.6 × 101 CFU/mL. No cross-reactions were detected when genomic DNA extracted from 12 different B. cereus strains and 20 other bacterial foodborne strains were tested, suggesting that the assay is highly specific. Finally, we evaluated the practical applications of the CPA assay for the detection of B. cereus in 150 food samples and found that its sensitivity and specificity, compared with real-time PCR, were approximately 98.18 and 100%, respectively. In conclusion, CPA combined with nucleic acid detection strips is easy to perform, requires simple equipment, and offers highly specific and sensitive B. cereus detection.
Collapse
Affiliation(s)
- Jing Zhang
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| | - Biao DI
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| | - Hongbo Shan
- ADICON Clinical Laboratory, Inc., No. 398 Tianmushan Road, Hangzhou, 310023, Zhejiang, People's Republic of China
| | - Junhua Liu
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| | - Yong Zhou
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| | - Huiling Chen
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| | - Lin Hu
- Ustar Biotechnologies (Hangzhou) Co., Ltd., 3766 Nanhuan Road, Hangzhou, 310012, Zhejiang, People's Republic of China
| | - Xinwei Wu
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| | - Zhijun Bai
- Guangzhou Center for Disease Control and Prevention, 1 Qide Road, Guangzhou, 510440, Guangdong, People's Republic of China (ORCID: https://orcid.org/0000-0002-8377-2393 [Z.B.])
| |
Collapse
|